Experimental T-Cell therapy for liver cancer shows early promise but trial halted
Disease control
Terminated
This early-stage trial tested a new treatment called ET140203 T cells for adults with advanced liver cancer that had not responded to other therapies. The treatment uses a patient's own immune cells, modified to target cancer cells. The study was stopped early after enrolling onl…
Phase: PHASE1 • Sponsor: Eureka Therapeutics Inc. • Aim: Disease control
Last updated May 17, 2026 02:04 UTC